Antibody

1,032개 · ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved1,032 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

AntibodyLimited DatastaleChinese PLA General HospitalPhase 1

PIN+sintilimab (PIN+sintilimab)

Colorectal Cancer; Adult · Colorectal Cancer

#ColorectalCancer#Antibody#Phase1#monoclonal-antibody#Adult+1
Trials 1Status Recruiting
AntibodyLimited DatastaleJanssenApproved

PRECISION dosing Infliximab (PRECISION dosing Infliximab)

Inflammatory Bowel Disease · Inflammatory Bowel Disease

#InflammatoryBowelDisease#Antibody#Approved#monoclonal-antibody#Janssen
Trials 1Status Active
AntibodyLimited DatastaleThe Netherlands Cancer InstitutePhase 3

PTC+Pertuzumab (PTC+Pertuzumab)

Breast Cancer; HER2 Positive · HER2

#HER2#Antibody#Phase3#monoclonal-antibody#BreastCancer+2
Trials 1Status Recruiting
AntibodyLimited DatastaleSCRI Development Innovations, L…Phase 1

PTK787/ZK222584 and Bevacizumab (PTK787/ZK222584 and Bevacizumab)

Refractory Malignancy; Advanced Malignancies · FRα

#FR#Antibody#Phase1#monoclonal-antibody#RefractoryMalignancy+2
Trials 1Status Active
AntibodyLimited DatastaleJiangsu HengruiPhase 2

PVE+cTACE+Camrelizumab+Apatinib (PVE+cTACE+Camrelizumab+Apatinib)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Phase2#monoclonal-antibody#Jiangsu
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 2

atezolizumab (Tecentriq, PXS-5505 and Atezolizumab and Bevacizumab)

Hepatocellular Carcinoma; Cancer of Liver · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Phase2#monoclonal-antibody#CancerofLiver+1
Trials 1Status Discontinued
AntibodyLimited DatastaleAbbVie (prior sponsor, Abbott)Phase 3

Palivizumab (Palivizumab)

Respiratory Syncytial Virus Infection · Respiratory Syncytial Virus Infection

#RespiratorySyncytialVirusInfecti#Antibody#Phase3#monoclonal-antibody#AbbVie
Trials 1Status Active
AntibodyLimited DatastaleJanssenApproved

Palmitoleic Acid + Infliximab (Palmitoleic Acid + Infliximab)

Crohn's Disease · Crohn's Disease

#CrohnsDisease#Antibody#Approved#monoclonal-antibody#Janssen
Trials 1Status Recruiting
AntibodyLimited DatastaleKyntra BioPhase 2

Pamrevlumab (Pamrevlumab)

Idiopathic Pulmonary Fibrosis · Idiopathic Pulmonary Fibrosis

#IdiopathicPulmonaryFibrosis#Antibody#Phase2#monoclonal-antibody#Kyntra
Trials 1Status Active
AntibodyLimited DatastaleChinese PLA General HospitalPhase 2

Pancreatic cancer: Tunlametinib + cetuximab β (Pancreatic cancer: Tunlametinib + cetuximab β)

Treatment for Advanced Colorectal Cancer; Treatment for Advanced Pancreatic Cancer · Treatment for Advanced Colorectal Cancer

#TreatmentforAdvancedColorectalCa#Antibody#Phase2#monoclonal-antibody#TreatmentforAdvancedPancreaticCa+1
Trials 1Status Recruiting
AntibodyLimited DatastaleChinese PLA General HospitalPhase 2

Pancreatic cancer: Tunlametinib +Nimotuzumab (Pancreatic cancer: Tunlametinib +Nimotuzumab)

Treatment for Advanced Colorectal Cancer; Treatment for Advanced Pancreatic Cancer · Treatment for Advanced Colorectal Cancer

#TreatmentforAdvancedColorectalCa#Antibody#Phase2#monoclonal-antibody#TreatmentforAdvancedPancreaticCa+1
Trials 1Status Recruiting
AntibodyLimited DatastaleAmgenPhase 2

ABX-EGF (Panitumumab, Panitumumab (ABX-EGF))

Colorectal Cancer; Non-Small Cell Lung Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#monoclonal-antibody#Non-SmallCellLungCancer+1
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 2

Pegylated Liposomal Doxorubicin (Doxil, Pegylated Liposomal Doxorubicin, Pegylated Liposomal Doxorubicin (Doxil) and Rituximab)

Non-Hodgkin's Lymphoma; Burkitt Lymphoma · Non-Hodgkin's Lymphoma

#Non-HodgkinsLymphoma#Antibody#Phase2#monoclonal-antibody#BurkittLymphoma+1
Trials 1Status Discontinued
AntibodyLimited DatastaleShanghai JMT-Bio Inc.Phase 2

Pembolizumab (Pembolizumab)

HER2-positive Gastric Cancer · HER2

#HER2#Antibody#Phase2#monoclonal-antibody#HER2-positiveGastricCancer+1
Trials 1Status Recruiting
AntibodyLimited DatastaleDana-Farber Cancer InstitutePhase 2

Pembroluzimab (Pembroluzimab)

HPV-positive Oropharyngeal Squamous Cell Carcinoma; Oropharyngeal Squamous Cell Carcinoma · HPV-positive Oropharyngeal Squamous Cell

#HPV-positiveOropharyngealSquamou#Antibody#Phase2#monoclonal-antibody#OropharyngealSquamousCellCarcino+1
Trials 1Status Recruiting
AntibodyLimited DatastaleEastern Hepatobiliary Surgery H…Phase 2

durvalumab (Imfinzi, Pemigatinib and Durvalumab)

Biliary Tract Carcinoma; Cholangiocarcinoma · Biliary Tract Carcinoma

#BiliaryTractCarcinoma#Antibody#Phase2#monoclonal-antibody#Cholangiocarcinoma+1
Trials 1Status Recruiting
AntibodyLimited DatastaleXijing HospitalPreclinical

Penpulimab combination with anlotinib and chemotherapy (Penpulimab combination with anlotinib and chemotherapy)

Gastric Cancer · Gastric Cancer

#GastricCancer#Antibody#Preclinical#monoclonal-antibody#Xijing
Trials 1Status Active
AntibodyLimited DatastaleRennes University HospitalPhase 3

Perfusion of treatment Ocrelizumab (Perfusion of treatment Ocrelizumab)

Multiple Sclerosis; Relapsing-remitting Multiple Sclerosis · Multiple Sclerosis

#MultipleSclerosis#Antibody#Phase3#monoclonal-antibody#Relapsing-remittingMultipleScler+1
Trials 1Status Recruiting
AntibodyLimited DatastaleRochePhase 3

Perfusion of treatment Rituximab (Perfusion of treatment Rituximab)

Multiple Sclerosis; Relapsing-remitting Multiple Sclerosis · Multiple Sclerosis

#MultipleSclerosis#Antibody#Phase3#monoclonal-antibody#Relapsing-remittingMultipleScler+1
Trials 1Status Recruiting
AntibodyLimited DatastaleEli LillyPhase 1

Peri operative Cetuximab. (Peri operative Cetuximab.)

Colon Cancer · Colon Cancer

#ColonCancer#Antibody#Phase1#monoclonal-antibody#Eli
Trials 1Status Discontinued

37 / 52 pages

← PreviousNext →